Immunoreactivity in lung cancer.
作者信息
Mentzer S J
机构信息
Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
出版信息
Chest Surg Clin N Am. 1995 Feb;5(1):57-71.
PMID:7743148
Abstract
Lung cancer has been associated with suppression of the cellular immune system. Recent experimental evidence suggests that recognition of HLA class I molecules by cytolytic T lymphocytes is important for tumor resistance. Augmentation of this interaction may soon play a role in cancer therapy.
摘要
Zotero 插件